A phase I trial of PR-104, a pre-prodrug of the bioreductive prodrug PR-104A, given weekly to solid tumour patients

by Amies Karen, Hill Andrew, Wilson William R, Gu Yongchuan, McKeage Mark J, Melink Teresa J, Jameson Michael B
Published 2011-10-01

PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours

by McKeage Mark J, Jameson Michael B, Ramanathan Ramesh K, Rajendran Joseph, Gu Yongchuan, Wilson William R, Melink Teresa J, Tchekmedyian N
Published 2012-10-01